Meeting
2015 Gastrointestinal Cancers Symposium
Paclitaxel, carboplatin, and capecitabine (TCX) with and without radiation in locally advanced and metastatic distal esophageal and esophagogastric junction cancer: A single-center retrospective review.
Authors
Peter Joel Hosein
University of Kentucky, Lexington, KY
Peter Joel Hosein , Neha Ray , Lowell Brian Anthony , Ching-Wei David Tzeng , Mahesh R. Kudrimoti , Ronald McGarry , Jeremiah Thomas Martin , Katie E Long , Colleen Overly , Philip A. DeSimone
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 197)
DOI
10.1200/jco.2015.33.3_suppl.197
Abstract #
197
Poster Bd #
D45
Abstract Disclosures
Similar Posters
Poster
2013 Gastrointestinal Cancers Symposium
Single-center experience with paclitaxel (T), carboplatin (C), and capecitabine (X) in the treatment of advanced esophagogastric cancer.
First Author: Carl Ruoff
Poster
2013 ASCO Annual Meeting
Pertuzumab (P) with trastuzumab (T) and chemotherapy (CTX) in patients (pts) with HER2-positive metastatic gastric or gastroesophageal junction (GEJ) cancer: An international phase III study (JACOB).
First Author: Josep Tabernero
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Metronomic oral cyclophosphamide as maintenance therapy in metastatic pancreatic ductal adenocarcinoma.
First Author: Michele Reni
Poster
2018 Gastrointestinal Cancers Symposium
Nonoperative management of locally advanced esophageal and junctional (GEJ) cancers: The University of Rochester experience.
First Author: Rachel Julie David